when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 322 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Marketed
crizotinib
Xalkori (crizotinib)
Anaplastic Large Cell Lymphoma (ALCL)$PFE PFIZER INC
Marketed
cytarabine
Cytarabine
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Meitheal Pharmaceuticals Inc
Marketed
dabrafenib mesylate + trametinib dimethyl sulfoxide
Tafinlar + Mekinist (dabrafenib mesylate + trametinib dimethyl sulfoxide)
Anaplastic Thyroid Cancer$NVS NOVARTIS AG

page 7 of 11

131

Marketed

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)

Meitheal Pharmaceuticals Inc

Marketed

Vizimpro (dacomitinib)

Non-Small Cell Lung Cancer$PFE PFIZER INC

Marketed

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Hisun Pharmaceutical USA Inc

Marketed

Nubeqa (darolutamide)

Castration-Resistant Prostate Cancer (CRPC) Bayer HealthCare Pharmaceuticals Inc

Marketed

daunorubicin hydrochloride

Daunorubicin Hydrochloride

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Hisun Pharmaceutical USA Inc

Marketed

degarelix acetate

Firmagon (degarelix acetate)

Metastatic Prostate Cancer Ferring Pharmaceuticals Inc

Marketed

Unituxin (dinutuximab)

Neuroblastoma$UTHR UNITED THERAPEUTICS Corp

Marketed

dordaviprone hydrochloride

Modeyso (dordaviprone hydrochloride)

Glioma$JAZZ Jazz Pharmaceuticals plc

Marketed

Copiktra (duvelisib)

T-Cell Lymphomas Secura Bio Inc

Marketed

elacestrant hydrochloride

Orserdu (elacestrant hydrochloride)

Metastatic Breast Cancer A. Menarini Industrie Farmaceutiche Riunite Srl

Marketed

Empliciti (elotuzumab)

Refractory Multiple Myeloma Bristol-Myers Squibb Co

Marketed

enasidenib mesylate

Idhifa (enasidenib mesylate)

Refractory Acute Myeloid Leukemia Bristol-Myers Squibb Co

Marketed

Rozlytrek (entrectinib)

Non-Small Cell Lung Cancer F. Hoffmann-La Roche Ltd

Marketed

eribulin mesylate

Halaven (eribulin mesylate)

Liposarcoma Eisai Co Ltd

Marketed

erlotinib hydrochloride

Erlotinib Hydrochloride

Non-Small Cell Lung Cancer NATCO Pharma Inc.

Marketed

ethacrynate sodium

Ethacrynate Sodium

Hepatic Edema SteriMax Inc

Marketed

ethacrynic acid

Ethacrynic Acid

Lymphedema Agnitio Inc

Marketed

Pepcid (famotidine)

Acid Indigestion (Heartburn/Pyrosis)$KVUE Kenvue Inc.

Marketed

Tascenso ODT (fingolimod [INN])

Multiple Sclerosis Cycle Pharmaceuticals Ltd

Marketed

Adenocarcinoma Of The Gastroesophageal Junction Fresenius Kabi USA LLC

Marketed

fludarabine phosphate

Fludarabine Phosphate

B-Cell Chronic Lymphocytic Leukemia Areva Pharmaceuticals Inc

Marketed

Metastatic Prostate Cancer Par Pharmaceutical Inc

Marketed

Non-Small Cell Lung Cancer Actavis Laboratories NY Inc (Inactive)

Marketed

gemtuzumab ozogamicin

Mylotarg (gemtuzumab ozogamicin)

Refractory Acute Myeloid Leukemia$PFE PFIZER INC

Marketed

gilteritinib fumarate

Xospata (gilteritinib fumarate)

Refractory Acute Myeloid Leukemia Astellas Pharma US Inc

Marketed

givinostat hydrochloride

Duvyzat (givinostat hydrochloride)

Polycythemia Vera Italfarmaco SpA

Marketed

Daurismo (glasdegib)

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$PFE PFIZER INC